Home / Recalls / EPI Health, LLC / D-0120-2020

D-0120-2020 Class III Terminated

Recalled by EPI Health, LLC — Charleston, SC

FDA drug recall D-0120-2020 was initiated by EPI Health, LLC on Aug 26, 2019 and is designated Class III. Reason for recall: Failed Dissolution Specifications: The recall status is terminated (terminated Aug 18, 2021). Affected quantity: 1,626 5-count bottles.

Recall details

Product Type: Drugs
Report Date: Oct 2, 2019
Initiation Date: Aug 26, 2019
Termination Date: Aug 18, 2021
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 1,626 5-count bottles

Product description

minolira (minocycline hydrochloride) extended-release tablets 135 mg* Physician Sample Not for Sale 5 Tablets, Rx Only, Mfg by: Dr. Reddy's Laboratories Limited, FTO-SEZ, Process Unit-01 Devunipalavalasa Village Srikakulam (District) Andhra Pradesh, INDIA. Manufactured for: EPI Health, LLC 134 Columbus St. Charleston, SC 29403 USA. NDC 71403-102-05.

Reason for recall

Failed Dissolution Specifications:

Distribution pattern

Firm recalling only from EPI Field Representatives.

Code information

Lot# T900093, Exp 11/2020

Source

Dataset: openFDA drug recall enforcement reports
FDA record: This recall in openFDA (JSON)
Enforcement Report: Search FDA's Enforcement Report for D-0120-2020
openFDA file date: Nov 10, 2026
Loaded by RegDataLab: Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.